Add BrightSurf on Google Email

Researchers identify enzyme linked to colitis

A Rutgers-Newark study discovered that lysozyme in the gut stimulates inflammation in some people with ulcerative colitis, leading to ulcers and sores in the large intestine. The study may help develop future treatments for inflammatory bowel disease by gaining insights into immune balance.

SourceRutgers University·JournalImmunity·DateAug 18, 2020

Cystic fibrosis patients may breathe easier, thanks to bioengineered antimicrobials

Cystic fibrosis patients may benefit from a new therapeutic strategy that targets deadly bacterial infections by manipulating the binding of antimicrobials in mucus. By reducing the charge on lysozyme, researchers found it could float independently in the mucus and kill bacteria effectively.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalProceedings of the National Academy of Sciences·DateSep 24, 2007